Recent advances in hemostatic risk factors and cardiovascular diseases

Fibrinolysis and Proteolysis

Volumn 11, Issue SUPPL. 1, 1997, Pages 31-34

  Wu, K K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY THROMBOSIS; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; FIBRIN FORMATION; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030726143     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(97)80019-7     Document Type: Conference Paper

References (22)

1. Meads T W, Chakrabarti R, Haines A P, North W R S, Stirling Y, Thompson S G. Hemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; I: 1050-1054.
2. Meads T W, Mellows S, Brozovic M et al. Hemostatic function and ischemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537.
3. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505.
4. Kännel W B, Wolf P A, Castelli W P: D'Agostino R B. Fibrinogen and risk of cardiovascular disease, the Framingham Study. JAMA 1987; 258: 1183-1186.
5. Yarnell J W G, Baker I A, Sweetnam P M et al Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation 1991; 83: 836-844.
6. Heinrich J, Balleisen L, Schultz H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM Study in healthy men. Arterioscl Thromb 1994; 14: 54-59.
7. Thomson S G, Kienast J, Pyke S D M, Haverkate F, van de Loo J C W. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. New Engl J Med 1995; 332: 635-641.
8. Hamsten A, Wiman B, Faire Ude, Blombäck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. New Engl J Med 1985; 313: 1557-1563.
9. Wu K K. Platelet activation mechanisms and markers in arterial thrombosis. J Intern Med 1966; 239: 17-34.
10. Trip M D, Cats V M, Van Capelle F J L, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. New Eng J Med 1990; 322: 1549-1554.
11. Liuzzo G, Biasucci L M, Gallimore R, Grillo R L, Rebuzzi A G, Pepys M B, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. New Eng J Med 1994; 331: 417-424.
12. Salonen R, Seppanen K, Rauramaa R, Salonen J T. Prevalence of carotid atherosclerosis and serum cholesterol levels in Eastern Finland. Atheroscl 1988; 8: 788-792.
13. Wu K K, Folsom A R, Heiss G, Davis C E, Conlan M G, Barnes R. Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early results of the ARIC study. Ann Epidemiol 1992; 2: 471-480.
14. Folsom A R, Wu K K, Shahr E, Davis C E. Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arteriosol Thromb 1993; 13: 1829-1836.
15. Tracy R P, Bovill E G, Yanez D, Pasty B M, Fried L P, Heiss G, Lee M, Polak J F, Savage P J. Fibrinogen and factor VIII but not factor VII are associated with measures of subclinical cardiovascular disease in the elderly. Results from the cardiovascular health study. Arterioscl Thromb Vasc Biol 1995; 15: 1269-1279.
16. Ghaddar H M, Cortes J, Salomona V, Kark J D, Davis C E, Folsom A R, Heiss G. Correlation of specific platelet activation markers with carotid arterial wall thickness. Thromb Haemost 1995; 74: 943-948.
17. Salonen R, Salonen J T. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Arteroscl 1990; 81: 33-40.
18. Salomaa V, Stinson V, Kark J D, Folsom A R, Davis C E, Wu K K. Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Circulation 1995; 91: 284-290.
19. Ye S, Green F R, Scarabin P Y, Nicand V, Bard L, Dawson S J, Humphries S E, Evans A, Lue G, Cambou J P, Arveiler D, Henney A M, Cambien F. The 4G/5G genetic polymorphism in the promoter of the PAI-1 gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM Study. Thromb Haemost 1995; 74: 837-841.
20. Green F, Kelleher C, Wilkes H, Temple A, Meads T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy subjects. Arterioscler Thromb 199; 11: 540-546.
21. Humphries S E, Cook M, Dubowitz M, Stirling Y, Meads T W. Role of genetic variation at fibrinogen locus in determination of plasma fibrinogen concentration. Lancet 1987; 1: 1452-1455.
22. Folsom A R, Conlan M G, Davis C E, Wu K K. Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Ann Epidemiol 1992; 2: 481-494.